FDA Investigator Barbara A Burke
Barbara A Burke has conducted inspections on 26 sites in 2 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
26
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Japan
FDA Investigators that have inspected at least one site in common with Barbara A Burke:
Amanda B Athey,
Amy A Johnson,
Amy C Amaro,
Amy Wyan Mai,
Ana P Barido,
Ana S Cabrera,
Armando P Zamora,
Ashley M Whitehurst,
Barbara A Gullick,
Barbara J Holladay,
Brandon L Mariner,
Brian S Lynch,
Celeta S Coves,
Charles D Boison,
Charles M Kerns, BLT DO,
Christine W Twohy,
Donna D Gallien, MPH,
Edward P Potter,
Elizabeth A Laudig,
Erika M Wilkerson,
Esther A Ofori,
Gail L Katz,
Gerald Mierle,
Ingrid Y Johnson,
James T Mccoy,
James W Leonette,
Jeanne D Shaffer,
Joan A Loreng,
Joseph W Matthews,
Krista N Flores,
La Tasham Gunter,
Lakisha M Williams,
Laurie A Haxel,
Laurissa S Flowers,
Laverne Puckett,
LCDR Anastasia M Piliafas Brown,
Lee Terry Moore,
Linda S Mattingly,
Lori A Holmquist,
Lori S Lawless,
LT Melanie M Mayor, USPHS,
Luis A Carrion,
Lynette P Salisbury,
Margaret Torres Vazquez,
Marion W Nadeau,
Merideth K Rose,
Michele M Falchek,
Mizanne E Lewis,
Nancy L Meade,
Natasha A Dezinna,
Nerizza B Guerin,
Nisha C Patel,
Patricia A Morrow,
Paula J Bretz,
Regina Gibson Melton,
Shavon L Square,
Shelley H Beausoleil,
Shusheen A Alexander,
Stacey A Priest,
Stephanie Mangigian, MS/OSH, RN,
Tamika E Allen, RN,
Tania E Vizcaino,
Tania Y Hall,
Vesna V Stanoyevitch,
Vien Q Le,
Wanda Y Fields,
Wanda Y Honeyblue,
Young M Yoon
Barbara A Burke's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | FDA 483 | American National Red Cross - Form 483, 2000-01-24 |
March, 2000 | EIR | Matz, Jonathan MD - EIR, 2000-03-28 |
June, 2001 | FDA 483 | Plasma Protein Therapeutics Association - Form 483, 2001-06-22 |
June, 2001 | EIR | Plasma Protein Therapeutics Association - EIR, 2001-06-22 |
January, 2001 | FDA 483 | UMD Medical System Blood Bank - Form 483, 2001-01-17 |
March, 2000 | FDA 483 | Atlantic Asthma & Allergy Center - Form 483, 2000-03-28 |
February, 2000 | FDA 483 | American National Red Cross - Form 483, 2000-02-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more